Pfizer's Covid-19 vaccine is considered by healthcare authorities to be safe and effective, with data gathered from billions ...

Both stocks boast high yields, deep pipelines, and robust underlying businesses. They should continue rewarding shareholders ...

A German court on Wednesday ruled that Pfizer and its partner BioNTech violated a COVID-19 vaccine patent held by Moderna. In ...

Wolf, who stated that she is not vaccinated against Covid-19, claimed that live birth rates have dropped by 13-20%, ...

Pregnant women can get the COVID-19 vaccine without any fear of causing birth defects in their unborn child, a new st ...

As we head into winter illness season, the SMC asked experts for the latest on ou. An updated vaccine targeting new COVID ...

The Pfizer/BioNTech bivalent COVID-19 vaccine (Original and Omicron BA.4/BA.5) has the FDA’s EUA for use in individuals 5 years and over as a single booster dose administered at least two months ...

Pfizer’s PFE stock has risen 5.9% in the past three months. The stock has started to show a consistent increase, with some ...

Pfizer stock has delivered its long-term shareholders a dividend that has grown for 16 consecutive years. The pace of those ...

Pfizer has said it will shed staff and cut its operating costs by around $3.5 billion, as it faces a shortfall in COVID-19 vaccine and treatment sales, with revenues now expected to be down around ...

BioNTech's Q4 revenue beat estimates despite lower COVID-19 vaccine sales. The company advances oncology programs, with key ...

Another recent federal study, published in the journal JAMA Pediatrics in February, showed approximately 1.01 million ...